Healionics, a developer of biomaterial-based medical devices, announced it has been awarded a $1.25M Small Business Innovation Research grant by the National Heart, Lung, and Blood Institute to support the commercialization of its STARgraft vascular graft.
The grant was provided under the National Institutes of Health Commercialization Readiness Pilot Program, which provides additional technical assistance and late-stage R&D support not typically covered within small business awards to help products get to market.
“We appreciate NHLBI’s recognition of STARgraft’s potential to provide more reliable vascular access for dialysis patients,” said Mike Connolly, Chief Executive Officer of Healionics. “These funds will help us complete testing, pursue regulatory clearance, and prepare for market launch.“